Clincosm LogoSign in Get a demo

light chain deposition disease

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

Active, not recruiting
Has Results
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease
  • Denver, Colorado
  • +6 more
Aug 24, 2022

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Recruiting
  • Multiple Myeloma
  • +11 more
  • No intervention
  • Beijing, China
    Peking University First Hospital
Apr 21, 2022

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in United States (melphalan, dexamethasone, bortezomib)

Completed
Has Results
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Scottsdale, Arizona
  • +208 more
Jan 12, 2022

Multiple Myeloma, Amyloidosis, Cryoglobulinemia Trial in Chapel Hill

Recruiting
  • Multiple Myeloma
  • +8 more
    • Chapel Hill, North Carolina
      North Carolina Cancer Hospital
    Nov 30, 2021

    IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

    Recruiting
    • IgA Monoclonal Gammopathy
    • +8 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Oct 18, 2021

    Light Chain Deposition Disease, Smoldering Plasma Cell Myeloma Trial in Ireland, Puerto Rico, United States (Clinical

    Active, not recruiting
    Has Results
    • Light Chain Deposition Disease
    • Smoldering Plasma Cell Myeloma
    • Anchorage, Alaska
    • +612 more
    Apr 29, 2021

    Light Chain Deposition Disease, Refractory Plasma Cell Myeloma Trial in Columbus (Diagnostic Laboratory Biomarker Analysis,

    Completed
    • Light Chain Deposition Disease
    • Refractory Plasma Cell Myeloma
    • Diagnostic Laboratory Biomarker Analysis
    • Wild-type Reovirus
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 14, 2015

    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +84 more
    • sunitinib malate
    • +2 more
    • Los Angeles, California
    • +10 more
    Mar 14, 2014